Episodes 241-255 of 762
The Alarming Shortage of ADHD Medication and Its Implications on Patients
NeuroFrontiersThe Alarming Shortage of ADHD Medication and Its Implications on Patients
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
NeuroFrontiersUnderstanding the Cellular Basis for Altered Cognition in Schizophrenia
Practices for Preventing Polypharmacy in Multiple Sclerosis
NeuroFrontiersPractices for Preventing Polypharmacy in Multiple Sclerosis
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiersFrom Assessment to Management: Tackling Catatonia in Schizophrenic Patients
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiersHow Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
- advertisement
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiersVisionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning Clinical Considerations for Patients with Multiple Sclerosis
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiersUnmet Needs in Rehabilitation Research for Multiple Sclerosis
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart MattersNew Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiersMS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
- advertisement
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiersTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiersAddressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease

















































